The Asia‑Pacific pain management drugs market was valued at approximately US $12.8 B in 2024 and is expected to reach US $21.5 B by 2033, growing at a CAGR of~6.5%. https://www.datamintelligence.com/research-report/asia-pacific-pain-management-drugs-market